January 21, 2025Heart
Coexistence of cardiac sarcoidosis and arrhythmogenic cardiomyopathy-associated genetic variants: a multicentre case-control study
Why the study?
Are there distinct clinical features associated with the coexistence of cardiac sarcoidosis and arrhythmogenic cardiomyopathy-associated genetic variants?
Design
Multicentre case-control study
Authors
Discussion
Loading...
Member takes
Implication
May prompt CS evaluation in ACM variant carriers with conduction disease; extends phenotypes but leaves management implications open.
Key Points
- Characterize the clinical features linked to the coexistence of cardiac sarcoidosis and arrhythmogenic cardiomyopathy-associated genetic variants.
- Multicentre case-control study assessing patients with cardiac sarcoidosis and arrhythmogenic cardiomyopathy-associated genetic variants.
- Coexistence of cardiac sarcoidosis and arrhythmogenic cardiomyopathy genetic variants is associated with PR prolongation, first-degree atrioventricular block, septal involvement, and paroxysmal atrial fibrillation.
Structured PICO
Are there distinct clinical features associated with the coexistence of cardiac sarcoidosis and arrhythmogenic cardiomyopathy-associated genetic variants?
P
Population
Individuals with cardiac sarcoidosis (CS) and arrhythmogenic cardiomyopathy (ACM)-associated genetic variants
O
Outcome
Distinct clinical features including PR prolongation, AVB1°, septal involvement and paroxysmal atrial fibrillation
Patients with ACM-associated genetic variants who present with conduction abnormalities or septal involvement should be evaluated for coexisting cardiac sarcoidosis.
Cite This Study
Rossi et al. (2025) studied this question.